Solitary Thyroid nodules Flashcards
1
Q
What are they?
A
great question need to figure that out
they are very common - 5% of women have one 95% will be benign - cyst - colloid nodule - benign follicular adenoma - hyperplastic nodule need to work out if malignant
2
Q
how do you know if the lump in the neck is the thyroid?
A
invested in pre-tracheal fascia
pain an uncommon feature - usually caused by an intra-thyroidal bleed into a cyst
3
Q
what are the important history/exam findings?
A
Family history of thyroid cancer Neck irradiation previously Neck nodes Hoarseness TSH measure USS-FNA (fine needle aspiration)
4
Q
FNA and USS grading
A
• Thy1 – inadequate • Thy2 – Benign U2 • Thy 3 (a/f) – Atypical U3 lobectomy • Thy4 – Prob malignant U4 thyroidectomy • Thy 5 – malignant U5 Thyroidectomy
5
Q
TMN grading
A
- T1 - Tumour size ≤ 2 cm
- T2 - Tumour size > 2 cm but ≤ 4 cm, limited to the thyroid.
- T3 - Tumour size >4 cm, limited to the thyroid or any tumour with minimal extrathyroidal extension (eg, extension to sternothyroid muscle or perithyroid soft tissues)
- T4a - Moderately advanced disease; tumour of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, oesophagus, or recurrent laryngeal nerve
- T4b - Very advanced disease; tumour invades prevertebral fascia or encases carotid artery or mediastinal vessels
- N0 - No regional lymph node metastasis
- N1 - Regional lymph node metastasis:
- N1a - Metastases to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes)
- N1b - Metastases to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, or V) or retropharyngeal or superior mediastinal lymph nodes (level VII)
- M0 No distant metastasis is found
- M1 Distant metastasis is present
6
Q
how is it managed?
A
low risk group - thyroid lobectomy high risk group (T3 or greater) - total thyroidectomy - consider radio-active iodine
7
Q
follow up if follicular or papillary
A
TSH lower level of normal (0.4-4 mU/l)
Thyroglobulin – protein precursor of T4/T3; made by thyroid follicular epithelial cell
Use Tg as a tumour cell marker for follow up of patient
Get TSH/Tg measured every 6 months for first 5 years then annually for next 5 years
Consider discharge at 5 years if low risk